NCT01908933View on ClinicalTrials.gov

Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema

PHASE3WithdrawnINTERVENTIONAL

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

EmphysemaChronic Obstructive Pulmonary Disease (COPD)

Interventions

DEVICE

AeriSeal Emphysematous Lung Sealant Syst

This is a prospective, open label, single-arm, multicenter, investigational study. Patients will receive either unilateral or bilateral AeriSeal System therapy as appropriate utilizing 20 mL/subsegment dosing at 2 to 4 subsegments.